Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news



Pharma techniques deliver high-dose omega-3 form

By Shane Starling , 11-May-2010
Last updated on 11-May-2010 at 14:59 GMT2010-05-11T14:59:21Z

Scottish omega-3 supplier, Equateq, says drug manufacturing separation methods are permitting it to deliver omega-3 EPA and DHA at 90 per cent combinations.

“We say that Maxomega-90 is like a blank canvas, allowing companies to mix lipid actives in almost any combination they require,” said Equateq chief executive officer, Adam Kelliher. “This will enable companies to define their product rationale and give a more clear, and focused offering.”

Equateq employs industrial-scale chromatography to make its omega-3 concentrates, rather than using more common distillation methods.

“The Maxomega-90 range is geared for the nutritional sector, allowing delivery of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in any ratio, from 80/10 to 10/80, with each offering always having at least 90 per cent total omega-3,” the company said.

The company said different formulations would target different health areas such as EPA-rich blends and anti-inflammation and DHA-rich blends and brain health, although only brain health claims for infants are as yet approved by the European Food Safety Authority (EFSA).

The company said Maxomega-90 can be blended with other lipids including omega-6 forms like GLA (gamma-linolenic acid).

“We think these can provide much-needed clarity in an increasingly cluttered marketplace,” Kelliher said.

Last year the company launched an omega-3/whey blend that sold for about €30 per kilogram but did not reveal pricing details this time around although it said it would be competitive and vary due to volumes.

The whey-omega-3 blend was aimed at the sports nutrition market.

The company’s Crystalpure separation methods enable saturates and mono-unsaturates to be transformed into crystals, which facilitates, “the physical separation of the polyunsaturated stream.”

Equateq splits its business between pharma and nutraceutical clients, noting its concentrations for pharma are all about being “super pure”, whereas nutra was much more about offering customised blends.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars